AndroidMonthly Archives: July 2014
THE IPR DIALOGUE : ‘INDIA’ and ‘US Pharmaceutical Companies’
The recurring cases of US Pharmaceutical giants being denied grant of patents has led to expression of serious concern regarding the protection of intellectual property in India. After the much publicized rejection of patent grant for Novartis’ anti-cancer drug Glivec, another US pharmaceutical company Abraxis BioSciences has been refused the patent for its anti-cancer drug,…
US statement; enforcement of IPR administration a main concern
Across the global market, Indian pharmaceutical segment is at a turning point, in the global economy. This is the time when this industry is all prepared for a launch; the area is loaded with regulatory concerns for active pharmaceutical ingredients (APIs) whilst there are quality issues taking a toll on ‘brand India’ in the global…
BRAND PROTECTION SOLUTIONS: KEEPING THE INTELLECTUAL PROPERTY PIRATES, THIEVES AND COUNTERFEITERS AT BAY
There is a thrill in creation. You can witness it in the eyes of kids proudly displaying their science projects once the schools open after summer. With their names boldly labeled on their works, they proclaim to the world that yes, this is my creation. Karl Benz must have felt the same way, when he…
My Caring Brands
Brands and Fakes has aligned the capabilities of the service delivery eco system with the industry verticals, so that the Brands under various industry verticals and sub verticals are able to get services from expertise in their specific domains.
